Chuikyo Subcommittee on Inpatient Medical Care, etc. Approves Verification Items and Schedule for FY2026 Revision (May 14, 2026) – Social Insurance Research Institute

News Highlights

The verification items and schedule for the FY2026 medical fee revision were approved at the Central Social Insurance Medical Council's Subcommittee on Inpatient Care meeting on May 14, 2026. Mid- to long-term management and succession strategies considering the revision cycle, economies of scale through group participation (maintaining facility standards, distributing equipment investment burdens), and the utilization of tax schemes including transitions to specific or social medical corporations are being discussed as key points for medical M&A and business succession.

M&A Medical Editorial Department's Perspective

The verification items and schedule for the FY2026 revision, approved at this meeting of the Central Social Insurance Medical Council's Subcommittee on Inpatient Care, are not merely preparations for the medical fee revision. In particular, joining a group that can offer "economies of scale" such as maintaining facility standards and distributing equipment investment burdens can be a realistic option for business continuity for regional medical institutions that are finding independent management increasingly difficult. Furthermore, utilizing tax schemes with a view to transitioning to specific or social medical corporations is essential for reducing tax burdens during succession and achieving smooth business succession. The perspective of incorporating the revision cycle into M&A and business succession strategies is becoming increasingly important.

Points Raised by This News

• Verification items and schedule for FY2026 revision specified, providing guidelines for mid- to long-term strategy development
• Economies of scale for "maintaining facility standards and distributing equipment investment burdens" motivate M&A considerations
• Utilizing tax schemes with a view to transitioning to specific/social medical corporations is key to succession
• An era where aligning revision cycles with business succession plans is essential

Practical Questions Arising from This News

• Regarding this revision, which specific medical departments or functions may see stricter facility standards or changes?
• Through group participation, what specific level of reduction in equipment investment burden or maintenance of facility standards can be expected?
• For which types of medical institutions are transitions to specific or social medical corporations particularly beneficial?

If You Feel "Should I Consult Too?"

With the verification items for the FY2026 revision now specified, a calm analysis is needed regarding how your institution's facility standards and revenue structure may be affected in the future. In particular, should options such as joining a group that offers economies of scale or transitioning to a specific/social medical corporation be considered, or should a succession strategy leveraging your institution's unique strengths be developed independently? This is a timely moment to consider consulting with experts to obtain objective advice for future management and succession.

M&A Medical (CentralMedience Inc.) is a business succession support service for medical corporations, hospitals, and clinics, certified by the Small and Medium Enterprise Agency as an M&A support institution. We provide comprehensive support.Success FeeWe handle consultations with strict confidentiality.Contact Us for a Free Consultation